0001562180-23-007553.txt : 20231103 0001562180-23-007553.hdr.sgml : 20231103 20231103161401 ACCESSION NUMBER: 0001562180-23-007553 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231102 FILED AS OF DATE: 20231103 DATE AS OF CHANGE: 20231103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WILLIAMS DOUGLAS E CENTRAL INDEX KEY: 0001184847 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39941 FILM NUMBER: 231376480 MAIL ADDRESS: STREET 1: C/O AMGEN INC STREET 2: ONE AMGEN CENTER DR CITY: THOUSAND OAKS STATE: CA ZIP: 91320-1799 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sana Biotechnology, Inc. CENTRAL INDEX KEY: 0001770121 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 188 EAST BLAINE STREET, SUITE 400 CITY: SEATTLE STATE: WA ZIP: 98102 BUSINESS PHONE: (206) 701-7914 MAIL ADDRESS: STREET 1: 188 EAST BLAINE STREET, SUITE 400 CITY: SEATTLE STATE: WA ZIP: 98102 4 1 primarydocument.xml PRIMARY DOCUMENT X0508 4 2023-11-02 false 0001770121 Sana Biotechnology, Inc. SANA 0001184847 WILLIAMS DOUGLAS E C/O SANA BIOTECHNOLOGY, INC. 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102 false true false false EVP & President, R&D false Restricted Stock Units 2023-11-02 4 A false 10000.00 0.00 A Common Stock 10000.00 10000.00 D Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. ("Sana") common stock. The restricted stock units will vest in full on January 2, 2025, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through such date. /s/ Julie Shah, Attorney-in-Fact for Douglas E. Williams 2023-11-03